Filter
281
Filtered Results: 281
Text search:
Chikungunya
Fever
Featured
Recommendations
37
New Publications
126
Language
Document type
No document type
164
Studies & Reports
36
Guidelines
34
Manuals
11
Strategic & Response Plan
11
Training Material
6
Resource Platforms
5
Fact sheets
5
Situation Updates
4
Infographics
4
Brochures
1
Countries / Regions
Global
24
Brazil
14
India
11
Latin America and the Carribbean
11
Indonesia
8
Congo, Democratic Republic of
7
Bangladesh
6
Western and Central Europe
5
Africa
5
Philippines
4
Paraguay
4
Argentina
3
Sierra Leone
2
Liberia
2
Togo
2
Chad
2
Kenya
2
Mozambique
2
Dominican Republic
2
Bolivia
2
South–East Asia Region
2
Venezuela
2
Nigeria
1
Mali
1
Pakistan
1
Syria
1
Tanzania
1
Thailand
1
South Africa
1
Central African Republic
1
North Macedonia
1
Honduras
1
Ecuador
1
Angola
1
Myanmar / Burma
1
Yemen
1
East and Southern Africa
1
Asia
1
Italy
1
Authors & Publishers
Publication Years
Category
Countries
65
Clinical Guidelines
36
Public Health
19
Key Resources
9
Pharmacy & Technologies
6
Capacity Building
4
Women & Child Health
1
Toolboxes
Zika
93
Rapid Response
61
NTDs
38
Planetary Health
18
COVID-19
12
Global Health Education
6
Ebola
4
Health Financing Toolbox
4
Caregiver
3
Natural Hazards
2
Pharmacy
2
Conflict
1
TB
1
Specific Hazards
1
AMR
1
The socioeconomic factors and public health inadequacies that facilitated the rapid spread of this infection continue to exist. As it is a new and emerging disease it has not received sufficient coverage yet in the medical curricula of Member States. Specific treatment is not available, and there is...
Information on Chikungunya Fever
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This documen...
Disease Control Division,
Standard Management Guideline
Directorate General of Health Services, Ministry of Health & Family Welfare
First Published: 15th May 2017
Chikungunya virus (CHIKV) is currently one of the most relevant arboviruses to public health. It is a member of the Togaviridae family and alphavirus genus and causes an arthritogenic disease known as chik... fever (CHIKF). It is characterized by a multifaceted disease, which is distinguished from other arbovirus infections by the intense and debilitating arthralgia that can last for months or years in some individuals. Despite the great social and economic burden caused by CHIKV infection, there is no vaccine or specific antiviral drugs currently available. Recent outbreaks have shown a change in the severity profile of the disease in which atypical and severe manifestation lead to hundreds of deaths, reinforcing the necessity to understand the replication and pathogenesis processes. CHIKF is a complex disease resultant from the infection of a plethora of cell types. Although there are several in vivo models for studying CHIKV infection, none of them reproduces integrally the disease signature observed in humans, which is a challenge for vaccine and drug development. Therefore, understanding the potentials and limitations of the state-of-the-art experimental models is imperative to advance in the field. In this context, the present review outlines the present knowledge on CHIKV epidemiology, replication, pathogenesis, and immunity and also brings a critical perspective on the current in vitro and in vivo state-of-the-art experimental models of CHIKF.
Case definitions, clinical classification, and disease phases Dengue, Chikungunya, and Zika
recommended
A person who lives in or has traveled in the previous 14 days to areas with dengue transmission, and presents with acute fever that has typically lasted 2 to 7 days, and two or more of the following clinical manifestations: nausea or vomiting, exant...
Chikungunya virus (CHIKV) is a re-emerging mosquito borne alphavirus responsible
for the recent outbreak in the Americas. Immunologically naïve population in the Americas favors the spread of epidemics. ... fever is characterized by an abrupt febrile illness, polyarthralgia and maculopapular rash. In chikungunya fever, shock or severe hemorrhage is very rarely observed; the onset is more acute and the duration of fever is shorter than dengue disease. The pain is much more pronounced and localized to the joints and tendons in chikungunya fever, in comparison to dengue fever. There is no specific and effective antiviral therapy and vaccines are still in trails. The only effective preventive measures consist of individual protection against mosquito bites and vector control. Disease prevention is important due to the
economic burden it entails. Clinicians need to distinguish chikungunya fever between dengue fever and other diseases to give a successful treatment and prevent disease spreading.
Dengue is a mosquito-borne viral disease that has rapidly spread to all regions of WHO in recent years. Dengue virus is transmitted by female mosquitoes mainly of the species Aedes aegypti and, to a lesser extent, Ae. albopictus. These mosquitoes are also vectors of ..., yellow fever and Zika viruses. Dengue is widespread throughout the tropics, with local variations in risk influenced by climate parameters as well as social and environmental factors.
The threat posed by Zika virus infection highlights the need to reinforce preparedness arrangements for mosquito-borne diseases in EU/EEA countries, especially for pathogens transmitted by Aedes aegypti and Aedes albopictus.
The aim of this document is to highlight measures that can effectively red...
Zika virus is primarily transmitted by the Aedes species of mosquito which is also responsible for the spread of dengue, Chikungunya and yellow fever viruses. In most areas, the primary vector of th...
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can...
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can...
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can be ...
PLOS One November 20, 2020 https://doi.org/10.1371/journal.pone.0241799 . The first autochthonous case of chikungunya virus (CHIKV) infection in Brazil was in September 2014 in the State of Amapá, and from there it rapidly spread across the country...
PLoS ONE 13(11): e0207554. https://doi.org/ 10.1371/journal.pone.020755
Chikungunya: WHO fact sheet on Chikungunya providing key facts and information on scope of the problem, who is at risk, prevention, WHO response.
Prevention recommendations at home. PREVENT dengue, chikungunya and Zika by eliminating mosquito breeding sites and protecting yourself from mosquito bites.
PLoS Neglected Tropical Diseases https://doi.org/10.1371/journal.pntd.0004762
This study shows the importance of an integrated entomological and medical surveillance for the evaluation of arboviral disease risk, which is a precondition for designing cost-effective vector control programs.
Evidence-based guidelines are one of the most useful tools for improving public health and clinical practice. Their purpose is to formulate interventions based on strong evidence of efficacy, avoid unnecessary risks, use resources efficiently, reduce clinical variability and, in essence, improve hea...
